- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02640768
Governance of Diabetes Management in Non-specialistic Hospital Settings
Panoramica dello studio
Descrizione dettagliata
The project aims at defining a model of care for hospitalized diabetic patients in non-specialist settings based on the national and international recommendations. This is a cluster randomized study to evaluate the efficacy of a structured education training program for physicians and nurses in improving an ad hoc composite performance score of diabetes management and some clinical outcomes. The study will be carried out in 6 hospitals of the Emilia-Romagna region in Italy and it will involve 3 different wards (internal medicine, intensive care unit, surgery). For each hospital one intervention and two controls wards will be randomly identified.
At baseline the clinical management of patients with stress hyperglycemia/diabetes will be assessed in all participating wards over a 3-month period. Then, a structured educational program regarding the management of stress hyperglycemia/diabetes in the inpatient setting will be carried out only in the intervention wards. This program will last 2 months. Health care professionals also will be trained in the regular use of appropriate management tools (hyperglycemia dedicated standard operation procedures, audits, etc.).
Three months after the end of the educational program, the 3-month assessment of clinical management of patients with stress hyperglycemia/diabetes will be repeated in all participating wards.
The assessment of clinical management of stress hyperglycemia/diabetes will be based on a set of clinical performance indicators concerning 5 major domains (admission assessment, glucose monitoring, medical therapy, management of consults, management of discharge). These indicators will be used to define a composite performance score of appropriateness and efficacy. The highest score (1) will be assigned when the indicator is monitored, the lowest (0) when the indicator will be not detected, according to the scoring method previously reported by Rossi et al. Therefore, the score of each domain will range between 0 and the number of indicators used to assess appropriateness and efficacy of that domain.
Domain 1 - Initial assessment: score 0-5
- records of admission glycemia
- records of fasting plasma glucose
- records of HbA1c
- appropriate diagnosis of stress hyperglycemia/diabetes mellitus according to ADA
- records of history of presence/absence of pharmacological diabetes therapy
Domain 2 - Glucose monitoring: score 0-4
- appropriate glucose monitoring: at least 80% of three daily preprandial glycemia or, in critically ill patients, monitoring according to the specific algorithm used in the ward
- presence and use of specific forms for glucose records
- presence of ward standing orders to recognize and correct hypoglycemia
- presence of ward standing orders to monitor and manage glucose in critically ill patients (Critically ill patients are defined as patients who require intensive care for acute critical illnesses, such as myocardial infarction, stroke, septic shock or severe respiratory failure, requiring intensive or semi-intensive therapy and, as a rule, not taking food orally during the first 24-72 hours)
Domain 3 - Medical therapy: score 0-2
- records of time and dose of insulin therapy
- interruption of Metformin therapy when indicated (correct indications to discontinuation of Metformin therapy were: any critical illness, acute renal, cardiac and/or respiratory failure, surgery or iodinated contrast agents administration.)
Domain 4 - Consults: score 0-2
- request and records of diabetes specialist consult
- request and records of nursing consult
Domain 5 - Management of discharge: score 0-3
- planning of diabetes follow-up visit after hospitalization
- patient education for home blood glucose self-monitoring
- patient education for all other aspects of diabetes management
The sum of the scores of each domain from 1 to 5 is the composite performance score.
The following clinical outcomes will be recorded both at baseline and 3 months after the end of the educational program in all participating wards.:
- all hypoglycemic events (blood glucose ≤ 70 mg/dl)
- severe hypoglycemic events (blood glucose ≤ 40 mg/dl with or without clouding of consciousness)
- difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
- achievement of glycemic goals: 4 consecutive blood glucose levels ≤ 130 mg/dl (preprandial) or ≤ 180 mg/dl (postprandial), or 4 consecutive blood glucose levels between 140 and 180 mg/dl in critically ill patients
- survival
- discharge condition: a score of 0 will be assigned in case of death or transfer to a higher intensity ward and score 1 in all other cases, i.e. home discharge or transferral to a lower intensity ward.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Bologna, Italia
- AUSL Ospedale Maggiore
-
Ferrara, Italia, 44121
- Azienda Ospedaliero-Universitaria
-
Modena, Italia
- AUSL Carpi
-
Parma, Italia, 43126
- Azienda Ospedaliero-Universitaria Parma
-
Piacenza, Italia, 29121
- AUSL Piacenza
-
Reggio Emilia, Italia, 42027
- AUSL Montecchio
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- patients with type 2 or type 1 diabetes or stress hyperglycemia
Exclusion Criteria:
- age <18,
- patients hospitalized for diabetic complications: ketoacidosis, hyperosmolar syndrome, hypoglycemic coma, pregnant diabetics or gestational diabetes
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: educational training
|
implementation of a structured educational program for physicians and nurses
|
|
Nessun intervento: no educational training
no educational training wards
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Composite performance score computed as the sum of the performance scores of all 5 domains of appropriateness and efficacy in both the intervention and the control wards
Lasso di tempo: 11 months
|
Efficacy of educational training will be evaluated as absolute change of the performance scores after the intervention compared to baseline in the two groups
|
11 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
hypoglycemic events in the intervention and control wards
Lasso di tempo: 11 months
|
rate difference of hypoglycemia events (blood glucose ≤ 70 mg/dl) in the intervention and control wards
|
11 months
|
|
severe hypoglycemic events in the intervention and control wards
Lasso di tempo: 11 months
|
rate difference of severe hypoglycemia events (blood glucose ≤ 40 mg/dL with or without clouding of consciousness) in the intervention and control wards
|
11 months
|
|
difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
Lasso di tempo: 11 months
|
difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
|
11 months
|
|
achievement of glycemic goals in the intervention and control wards
Lasso di tempo: 11 months
|
number of patients that achieve glycemic goals: 4 consecutive blood glucose levels ≤ 130 mg/dl (preprandial) or ≤ 180 mg/dl (postprandial), or 4 consecutive blood glucose levels between 140 and 180 mg/dl in critically ill patients
|
11 months
|
|
survival rate during hospitalization in the intervention and control wards
Lasso di tempo: 11 months
|
survival rate during hospitalization (score 1 for survival, score 0 for death)
|
11 months
|
|
discharge condition in the intervention and control wards
Lasso di tempo: 11 months
|
a score of 0 will be assigned in case of death or transfer to a higher intensity ward and score 1 in all other cases, i.e. home discharge or transferral to a lower intensity ward.
|
11 months
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Ivana Zavaroni, MD, Azienda Ospedaliero-Universitaria Parma
Pubblicazioni e link utili
Pubblicazioni generali
- Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521.
- Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, Argueta R, Hull BP, Zimmerman RS. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007 Jul;2(4):203-11. doi: 10.1002/jhm.188.
- American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012. No abstract available.
- Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellegrini F, Valentini U, Vespasiani G, Nicolucci A; AMD-QUASAR Study Group. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care. 2011 Feb;34(2):347-52. doi: 10.2337/dc10-1709.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- AOParma
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su educational training
-
Cairo UniversityCompletatoSclerosi multipla recidivante-remittenteEgitto
-
Mohammed V Souissi UniversityCompletato
-
Stanford UniversityCompletatoSindrome da deficit di attenzione e iperattivitàStati Uniti
-
Nottingham University Hospitals NHS TrustCompletato
-
Dario KohlbrennerCompletato
-
University of Maryland, College ParkNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletatoDisturbi percettivi uditivi | Problemi di invecchiamentoStati Uniti
-
KTO Karatay UniversityCompletatoIctus | Riabilitazione dell'ictusTacchino
-
Institut d'Investigació Biomèdica de Girona Dr....Attivo, non reclutanteRiabilitazione | Infezione respiratoria da COVID-19 | FisioterapistiSpagna
-
Chang Gung UniversityCompletato
-
Université de MontréalFonds de la Recherche en Santé du QuébecCompletato